Primus Medical Shanghai (PMS/China) and Progressive Group, Inc. (PGI/Taiwan) started as in vitro diagnostics (IVD) distribution companies in 1984. To better serve our clients, we realized that focusing solely on diagnostic market was no longer enough. Recognizing the potential of emerging medical device innovations from startups and academia, we understood that embracing these opportunities was essential to advancing healthcare and meeting a broader coverage of patient needs in China and Taiwan. To focus on these new opportunities, Progressive Venture Partners was founded in 1999 as a healthcare-focused investment firm, while PMS and PGI continued their distribution efforts as subsidiaries of Progressive Venture Partners. We are now interested in areas including aging, oncology, neurodegenerative diseases, stroke, sepsis, diabetes, wound care, incision wound care, in vitro diagnostics (IVD), and medical-related artificial intelligence products.

In the past 40 years, PMS and PGI have built solid direct sales and distribution networks throughout China and Taiwan. This strategic foundation has enabled Progressive Venture Partners to:

• Leveraging Market Knowledge and Support: Ensuring a streamlined process of product registration, reimbursement application, and market access for your products.

• Building KOL and Stakeholder Relationships: Leveraging strong connections with local KOLs and stakeholders to facilitate product awareness and acceptance.

• Providing Comprehensive Service: Offering patient-doctor education, market penetration, after-sales service, and technical support to sustain and grow your brand.

These strategies leverage our expertise and market access, helping newly invested products succeed and fast-tracking their commercialization journey in China and Taiwan.

In the product development stages, our extensive network of portfolio and partner companies helps guide your businesses through its formation stages and grow to its full market potential with business and scientific expertise.

Once your product is ready, our infrastructure provides a full product service that includes market access, product registration, gaining reasonable reimbursement, patient-doctor education, and building local KOL relationship. Simply put, we ensure your product is accessible to patients and successful in the market.